Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Felix GoeserBarbara SifftChristoph Stein-ThoeringerFedja FarowskiChristian P StrassburgPeter BrossartPaul G HigginsChristoph ScheidDominik WolfTobias A W HolderriedMaria J G T VehreschildMarta Rebeca Cruz AguilarPublished in: European journal of haematology (2021)
In our study, we observed positive effects on sr-GVHD after FMT without the occurrence of major adverse events. Although these findings are in line with published data on beneficial effects of FMT in sr-GvHD, further randomized clinical studies are urgently needed to better define the clinical validity including mode of action.